Pfizer, BioNTech ask U.S. regulators to OK COVID-19 vaccine for youths By Reuters


© Reuters

WASHINGTON (Reuters) – Pfizer Inc (NYSE 🙂 and BioNTech said Thursday they had asked U.S. regulators to approve the emergency use of their COVID-19 vaccine for children ages five to 11, Pfizer said in a post on Twitter (NYSE 🙂 .

“We and @BioNTech_Group have officially submitted our request to

@US_FDA for the Emergency Approval (EUA) of our # COVID19 vaccine in children 5 to

Disclaimer: Fusion Media would like to remind you that the data contained on this website is not necessarily real time or accurate. All CFDs (stocks, indices, futures) and forex prices are not provided by exchanges, but by market makers. Therefore, prices may not be accurate and may differ from the actual market price, meaning that prices are indicative and not suitable for trading purposes. Therefore, Fusion Media is not responsible for any trading losses you may incur as a result of using this data.

Fusion Media or any other person involved in Fusion Media assumes no liability for any loss or damage that might arise from reliance on the information contained on this website, including data, prices, charts and buy / sell signals. Please inform yourself comprehensively about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment.

You might also like

Leave A Reply

Your email address will not be published.